BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

Therapeutic Potential of Natural Pharmacological Agents in the Treatment of Human Diseases

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 127021 | https://doi.org/10.1155/2014/127021

Giovanna Simonetti, Anna Rita Santamaria, Felicia Diodata D'Auria, Nadia Mulinacci, Marzia Innocenti, Francesca Cecchini, Eva Pericolini, Elena Gabrielli, Simona Panella, Donato Antonacci, Anna Teresa Palamara, Anna Vecchiarelli, Gabriella Pasqua, "Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars", BioMed Research International, vol. 2014, Article ID 127021, 11 pages, 2014. https://doi.org/10.1155/2014/127021

Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars

Academic Editor: Aramati B. Reddy
Received05 Dec 2013
Accepted27 Mar 2014
Published23 Apr 2014

Abstract

For the first time, grape seed extracts (GSEs), obtained from wine and table cultivars of Vitis vinifera L., cultured in experimental fields of Lazio and Puglia regions of Italy and grown in different agronomic conditions, have been tested on 43 Candida species strains. We demonstrated a significant correlation between the content of the flavan-3-ols in GSEs extracts, with a polymerization degree ≥4, and anti-Candida activity. Moreover, we demonstrated that GSEs, obtained from plants cultured with reduced irrigation, showed a content of polymeric flavan-3-ols 250 mg/g with geometric mean MIC values between 5.7 and 20.2 mg/L against Candida albicans reference strains. GSE, showing 573 mg/g of polymeric flavan-3-ols, has been tested in an experimental murine model of vaginal candidiasis by using noninvasive in vivo imaging technique. The results pointed out a significant inhibition of Candida albicans load 5 days after challenge. These findings indicate that GSEs with high content of polymeric flavan-3-ols can be used in mucosal infection as vaginal candidiasis.

1. Introduction

Candida species are major human opportunistic fungal pathogens that cause both mucosal and deep tissue infections. The frequency of mucosal and cutaneous fungal infections has dramatically increased worldwide. Infection caused by Candida spp. affects 70–75% of women at least once during their life. Recurrent vulvovaginal candidiasis occurs in 5% of women with Candida vaginitis [1, 2]. Most of these infections are caused by Candida albicans (C. albicans) and among non-albicans Candida spp., C. glabrata, C. tropicalis, and C. krusei. Azoles are the most common antifungal agents available to treat topical Candida infections. However, these antifungal drugs have several defects related to clinical usage, such as low efficacy and side effects. Therefore, there is an urgent need of new antifungal agents [3]. Natural anti-infective agents represent a promising approach for the treatment of Candida infections [4]. Phytomedicine, which has historically been an important aspect of traditional medicine in nonindustrialized countries, is now becoming an integral part of healthcare in industrialized countries. Plants are the source of thousands of new phytochemicals, and different strategies can be applied to improve the yields of bioactive metabolites in the plant and to obtain chemically standardized extracts [5, 6]. Vitis vinifera L. is the most important fruit species in the world, cultivated especially in Mediterranean area. As reported by the wide literature [7], grapes are rich source of polyphenols, important secondary metabolites produced by higher plants, which play multiple essential roles in plant physiology and showed healthy properties in human organism, mainly as antioxidant, antiallergic, anti-inflammatory, anticancer, antihypertensive, renoprotective, and antimicrobial agents [8, 9]. GSEs are recognized as a complex mixture of monomeric, oligomeric, and polymeric flavan-3-ols. The principal monomers identified are (+)-catechin, (−)-epicatechin, (−)-epicatechin gallate (ECg), (−)-epigallocatechin (EGC), and (−)-epigallocatechin gallate (EGCg). Several fungi, including C. albicans, are sensitive to EGCg, the main component of green tea extracts [10]. The content of flavan-3-ols in seed grapes is influenced by several factors mainly cultivar, irrigation, nitrogen fertilization, delayed harvest, and storage conditions [11].

Moreover, the application of an extraction process suitable to efficiently recover the target metabolites and an appropriate analytical method for an accurate qualitative and quantitative determination of extract components are required.

In this work, for the first time, anti-Candida activity and chemical analysis of GSEs obtained from wine and table cultivars of Vitis vinifera L. grown in different agronomic conditions have been evaluated and compared with respect to their phenolic content. The HPLC method with a Poroshell column has allowed to quantify not only the flavan-3-ols oligomers but also the polymeric forms (polymerization degree >4) difficult to be detected with conventional reverse phase columns. Moreover, the effect of GSE treatment on an experimental murine model of vaginal candidiasis was evaluated for the first time by using noninvasive in vivo imaging technique.

2. Methods and Materials

2.1. Plant Material

Mature grapes were collected from different cultivars of Vitis vinifera L.: Michele Palieri (M. Palieri), Italia, Red Globe, Negroamaro, Pinot, Abbuoto, and Verdicchio. The cultivars M. Palieri, Italia, Red Globe, and Negroamaro were grown in the experimental farm of CRA-UTV in Turi (BA), during 2010 and 2011 with the “tendone” system, a typical cultivation method in the Puglia region (South Italy) whose climate is characterized by scarce rainfalls [12]. The vines were treated with reduced irrigation volume per hectare (1200 m3) (V1) or (2000 m3) (V2) and with reduced nitrogen fertilization (120 kg ha−1) (N1) or with 180 kg ha−1 (N2) that is the quantity generally used in the growing area. Fertilization was carried out at budding (mid-March) and during the growth of the green grapes (first ten days of July). The cultivars Verdicchio, Abbuoto, and Pinot were grown in the experimental field of Lazio region (Center of Italy), during vintages 2006, 2008, and 2011 in normal Mediterranean conditions. The average amount of rainfall accumulated between April and September in 2006, in 2008, and in 2011 has been 223 mm, 423 mm, and 245 mm, respectively. The cultivars had training system to Cordon Spur, with plant density of 2.60 × 1 m. In the examined years the same cultural practices were applied in the vineyard. All the grapes were harvested at technological maturation and frozen at −20°C. The seeds have been isolated immediately before use and subjected to extraction process.

2.2. Sample Preparation

The seeds were separated from the flesh and the skin, weighed, and put in liquid nitrogen in a porcelain mortar and ground to obtain a fine powder. They were extracted three times (24 hrs for each extraction) by the mixture EtOH/H2O (7 : 3 v/v) acidified with formic acid to pH 3; the ratio matrix/solvent was 1 g fresh weight/10 mL. After the removal of the solid residue, the extracts were dried (t ≤ 30°C), weighed, and redissolved in a suitable volume of the same extraction solution to obtain enriched extracts. The samples were centrifuged (12.000 rpm for 5 min) to obtain a limpid solution for the HPLC/DAD/MS analyses. Only the seeds of Abbuoto and Verdicchio cultivars (vintages 2006 and 2008) were treated with a different method using a buffer at pH 3.2 as extractive solution. This method was applied with the aim to simulate the wine-making process. The seeds were manually separated from the berries and extracted with 125 mL of the buffer solution for 144 hours at 30°C. The buffer composition consisted of tartaric acid 5 g; NaOH 1 N 22 mL; Na2S2O5 2 g; and EtOH 95% 120 mL.

2.3. HPLC/DAD/MS Analysis

The multistep elution method was applied: it started with 95%  H2O for 5 min, then with 86% H2O for 25 min, 84% H2O for 5 min; 82% H2O for 2 min, 80% H2O for 3 min and a plateau for 4 min, 70% H2O for 3 min and a plateau for 3 min, up to 20% H2O for 4 min and a plateau for 5 min; total time of analysis 59 min, equilibration time of 10 min, and a flow rate of 0.4 mL/min. The column was a Poroshell 120 EC18 (150 × 4.6 mm i.d., 2.7 μm) with a precolumn of the same phase maintained at 27°C; the eluents were H2O (pH 3.2 by HCOOH) and CH3CN, both of HPLC grade. The HPLC/ESI/MS analysis was carried out using a liquid chromatographic HP 1100 L equipped with an Electrospray (ESI) HP 1100 MDS mass detector with an API interface. The operative conditions of the mass spectrometer were nitrogen flux 10 L min−1, nebulizer pressure 30 psi, gas temperature 350°C, quadruple temperature 30°C, and capillary voltage 3000–4000 V. The experiments were carried out in negative and positive ionization modes, applying fragmentors between 60 and 220 V. The following standards were used for the identification: (+) catechin, (−) epicatechin, ECg, procyanidin B1, and procyanidin B2, all of high purity grade and purchased from Extrasynthese (France). The quantitative analysis of both phenol oligomers and polymers was carried out at 280 nm using only the procyanidin B2 as external standard in a concentration range 0.1–5.7 μg and a five-point calibration curve with of 0.999.

2.4. Organisms

For the in vitro antifungal evaluation, strains coming from the American Type Culture Collection (ATCC, Rockville, MD, USA), from the German Collection of Microorganisms (DSMZ, Braunschweig, Germany), and from the Pharmaceutical Microbiology Culture Collection (PMC, Department of Public Health and Infectious Diseases, Sapienza, Rome, Italy) were tested. The strains coming from ATCC were C. albicans ATCC (90028, 90029, 10261, 10231, 3153, and 24433), C. parapsilosis ATCC 22019. The strains coming from DSMZ were C. parapsilosis DSM 11224, C. krusei DSM 6128, and C. tropicalis DSM 11953. The strains coming from PMC were C. albicans PMC (1011, 1075, 1083, 1088, 1097, 1002, 1004, 1006, 1008, 1010, 1012, 1018, 1031, and 1032), C. parapsilosis PMC (0703, 0711, 0706, 0704, 0705, and 0712), C. tropicalis PMC (0908, 0910, 0912, 0913, and 0914), C. krusei PMC (0613, 0625, 0612, and 0622), and C. glabrata PMC (0805, 0849, 0843, and 0822). For the in vivo experiments C. albicans CA1398 carrying the ACT1p-gLUC59 fusion (gLUC59) and C. albicans CA1399 that did not express gLUC59 (control strain) were used [13]. The gLUC59 luciferase reporter has previously been described [13]. C. albicans gLUC59 and the control strain were cultured in YPD as previously described [14].

2.5. Antifungal Susceptibility Testing

The broth microdilution method to evaluate the susceptibility in vitro on strains of Candida spp. was performed according to standardized method for yeast [15, 16]. Briefly, the extracts were dissolved previously in dimethyl sulfoxide at concentrations 100 times higher than the highest test concentration [16]. The final concentration ranged from 0.25 to 512 for total dry seed extracts and from 0.125 to 128 mg/L for Fluconazole (FLC). Microdilution trays, containing 100 μL of serial twofold dilutions of seed extracts or FLC in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MI, USA), were inoculated with an organism suspension of 1.0 × 103–1.5 × 103 cells/mL. The panels were incubated at 35°C and the growth observed at 48 h. The minimal inhibitory concentration (MIC) was the lowest concentration that caused a prominent decrease (≥50%) in visible growth. The MIC90 was defined as the lowest drug concentration that caused ≥90% growth inhibition compared with the drug-free control. Medians, geometric means (GMs), and ranges were calculated.

2.6. In Vitro Induction of Resistance

C. albicans ATCC 10231 was cultured as previously described [17]. In particular, serial subcultures of C. albicans ATCC 10231 were performed in fresh medium every 48 hours, containing rising concentrations of  M. Palieri V1N1 2010 GSE (starting from 4 mg/L up to 128 mg/L). At the same time the same procedure was carried out for the control without addition of extract. The MIC was evaluated after 48 h of incubation (extracts concentration range 0.5–512 mg/L) according to the CLSI protocol [15].

2.7. Mice

Female CD1 mice obtained from Harlan Nossan Laboratories (Milan, Italy) were used at 4 to 6 weeks of age. Mice were allowed to rest for 1 week before the experiment; by that time the animals were roughly 5 to 7 weeks old. Mice were used under specific pathogen-free conditions that included testing sentinels for unwanted infections; according to the Federation of European Laboratory Animal Science Association standards, no infections were detected.

2.8. Infection and Treatment

Mice infection was performed as previously described with minor adaptations [18]. Mice were maintained under pseudoestrus condition by subcutaneous injection of 0.2 mg of estradiol valerate in 100 μL of sesame oil (Sigma-Aldrich) 5 days prior to infection and weekly until the completion of the study. Mice anaesthetized with 2.5–3.5 (v/v) isofluorane gas were infected with 10 μL of  cell/mL of C. albicans gLUC59 or the control strain. Cell suspensions were administered from a mechanical pipette into the vaginal lumen close to the cervix. To favor vaginal contact and adsorption of fungal cells, mice were held head down for 1 min following inoculation. Mice were then allowed to recover for 24–48 h, during which the Candida infection was established. The intravaginal treatment with FLC (200 mg/L, 10 μL/mouse) or with M. Palieri V1N1 2010 GSE (50 mg/mL, 10 μL/mouse) has begun 2 h before the challenge and then it was repeated every two days until day +8.

2.9. Monitoring of Mouse Vaginal Infection

After 2, 5, and 8 days after infection, 10 μL (0.5 g/L in 1 : 10 methanol : H2O) of coelenterazine (Synchem, OHM) was added to the vaginal lumen. Afterwards, mice were imaged in the IVIS-200TM imaging system (Xenogen Inc.) under anaesthesia with 2.5% isofluorane. Total photon emission from vaginal areas within the images (region of interest (ROI)) of each mouse was quantified with Living ImageR software package [19].

2.10. Statistical Analysis

In order to analyze the data among phenolic constituents and MIC values of dried GSEs obtained from selected cultivars of Vitis vinifera L., Pearson’s correlation coefficient was determined. A value of <0.01 was considered significant. Differences between FLC and M. Palieri V1N1 2010 GSE treated and saline treated mice were evaluated by Mann-Whitney -test. A value of was considered significant.

3. Results

3.1. In Vitro Antifungal Activity of GSEs

Seed extracts obtained by Vitis vinifera L., wine cultivars, Verdicchio and Abbuoto, cultured in experimental fields of Lazio region of Italy, during 2006 and 2008 vintages, showed great variability of antifungal activity against C. albicans, with GM MIC range from 44.22 mg/L to 203.19 mg/L and MIC90 values from 97 mg/L to 256 mg/L (Table 1). GSEs from the table cultivars M. Palieri, Red Globe, and Italia grown in the 2010 in the experimental farm of CRA-UTV Puglia region of Italy, subjected to reduction of irrigation volume (V1 and V2) and different nitrogen fertilization (N1 and N2), showed potent and comparable antifungal activity against C. albicans with a range of GM MIC values from 8.2 mg/L to 12.8 mg/L and MIC90 values from 17.9 mg/L to 29.8 mg/L (Table 2). Moreover, antifungal activity against non-albicans Candida spp. showed MIC values from 6.5 to 8.6 mg/L and MIC90 values from 14 to 18 mg/L (Table 3). The same cultivars harvested in 2011 and grown under the same agronomic conditions showed MIC values from 5.66 to 14.59 mg/L and MIC90 values from 17.55 to 29.17 mg/L for C. albicans reference strains demonstrating that the antifungal activity is reproducible over the years (Table 4). Negroamaro V2N2 and V1N2 (from Puglia region) grown in 2011 revealed MIC values against C. albicans reference strains of 10.7 mg/L, 20.2 mg/L, respectively (samples 13 and 14 of Table 5), while Pinot (from Lazio region), not subjected to controlled agronomic conditions of water and nitrogen, showed MIC values of 84.5 mg/L (sample 15 of Table 5).


Candida  albicans Verdicchio 2006Verdicchio 2008Abbuoto 2006Abbuoto 2008Fluconazole
MIC MIC MIC MIC MIC

ATCC900286412825625664128645120.58
ATCC3153641282562563264321281632
ATCC1026164128256128326464128432
ATCC1023132641282566412864128232
ATCC24433128256512256128128128128116

GM53.2097.01203.1925644.229764168.93.0324.25

Range32–12832–256128–512128–51232–12864–12832–128128–5120.5–168–32

The values are expressed as median of minimum inhibitory concentration (MIC) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3. : lowest drug concentration that prevented 90% of growth with respect to the untreated control. GM: geometrical mean of MIC.

Candida albicans M. PalieriV2N1M. PalieriV1N1Red GlobeV2N1Red GlobeV1N1ItaliaV2N2ItaliaV1N2Fluconazole
MIC MIC MIC MIC MIC MIC MIC

ATCC90028888168168328168160.58
ATCC3153864163281683216168161632
ATCC10261163216328328321632816432
ATCC900291664323216641632166416320.251
ATCC10231816816816832832832232
ATCC24433163216321616163216321616116
PMC10128321632864163216323232832
PMC101016323232323216641632832832
PMC1006816816832832832816832
PMC100881616168161632816161648
PMC108316321632328166483216320.532
PMC10971414244812110.564
PMC1088832832832163281616320.58
PMC107581648816163281616160.58
PMC10181616163283216328161616816
PMC1004166416323264326416163264832
PMC10111632163216816328328160.2532
PMC100286432643232832163216320.258
PMC1031832163286416328328160.2532
PMC1032163216321681632163216320.258

GM8.217.911.1820.610.4328.212.829.88.7719.29.2918.42.521.1

Range1–322–641–322–642–644–1284–644–641–322–641–321–640.125–641–128

The values are expressed in mg/L as median of minimum inhibitory concentration (MIC) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3. : lowest drug concentration that prevented 90% of growth with respect to the untreated control. GM: geometrical mean of MIC.

Candida spp.  M. PalieriV2N1M. PalieriV1N1RedGlobeV2N1RedGlobeV1N1ItaliaV2N2ItaliaV1N2Fluconazole
   MIC MIC MIC MIC MIC MIC MIC

krusei PMC0613816816816816816816816
krusei PMC06258848488848481632
krusei DSM 612848816888848481616
krusei PMC0612816816816816816816816
krusei PMC06228848484848481632
glabrata PMC08054328328648324324818
glabrata PMC0849484848416484814
glabrata PMC08434848484168828416
glabrata PMC0822163216321632832163216320.51
parapsilosis PMC07068168168324328168818
parapsilosis PMC070316168161632832161616160.54
parapsilosis ATCC2201981681681616161616161622
parapsilosis DSM11224832163283281683281612
parapsilosis PMC0704163232641632832163216160.51
parapsilosis PMC0711161616161616816161616160.52
tropicalis PMC091012120.520.521218416
tropicalis PMC090816161632163281616168320.52
tropicalis PMC091216321632163216641632163214
tropicalis DSM119531632326416328161632161618
tropicalis PMC091416161632163283216168160.52
tropicalis PMC09131632163216328641632163212
GM6.815.38.617.57.0187.017.17.114.66.5142.68.3
Range0.5–162–321–322–640.5–161–640.5–321–640.5–162–320.5–164–320.25–321–64

The values are expressed in mg/L as median of minimum inhibitory concentration (MIC) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3. GM: geometrical mean of MIC. : lowest drug concentration that prevented 90% of growth with respect to the untreated control.

Candida  albicans M. PalieriV2N1M. PalieriV1N1RedGlobeV2N1RedGlobeV1N1ItaliaV2N2ItaliaV1N2Fluconazole
MIC MIC MIC MIC MIC MIC MIC

ATCC900288168164168324168160.58
ATCC31531632163283216328164161632
ATCC1026116321632832816816816432
ATCC1023181616168161632416816232
ATCC24433163216328161632816416116

GM12.1222.1114.5923.166.9623.1612.1329.176.0617.555.6619.243.0325.6
Range8–3232–168–3216–644–1616–648–1616–644–88–324–88–320.5–168–32

The values are expressed in mg/L as median of minimum inhibitory concentration (MIC) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3. GM: geometrical mean of minimum inhibitory concentration. : lowest drug concentration that prevented 90% of growth with respect to the untreated control.

SampleFlavan-3-ols
mg/g
Pol 1 + 2
mg/g
G Mon + Olig
mg/g
Pol 1 + 2/
flavan-3-ols
Pol 1/Pol 2Pol 2
mg/g
MIC GM
mg/L

1Verdicchio 2006198.3156.54.90.791.660.253.2
2Abbuoto 200696.967.23.10.693.514.944.2
3Verdicchio 200869.132.84.10.474.26.3203.2
4Abbuoto 200898.138.910.100.406.25.464.0
5M. PalieriV2N1 2010820.0638.525.20.782.8168.010.6
6M. PalieriV1N1 2010748.1572.923.40.772.9146.911.6
7M. PalieriV2N1 2011581.1465.418.20.802.8122.412.1
8M. PalieriV1N1 2011617.6448.820.70.734.089.814.6
9ItaliaV2N2 2011460.4429.011.90.932.7115.96.1
10ItaliaV1N2 2011534.2514.55.40.961.7190.95.7
11Red GlobeV2N1 2011471.7404.928.40.863.688.07.0
12Red GlobeV1N1 2011300.5251.623.10.844.446.612.1
13NegroamaroV2N2 2011375.3354.42.40.942.2110.710.7
14NegroamaroV1N2 2011401.7306.79.00.764.160.120.2
15Pinot 2011229.5143.211.40.623.432.584.5

Flavan-3-ols: total sum of monomers, oligomers (degree of polymerization ≤ 3) and polymeric forms; Pol 1 + 2: polymeric forms (degree of polymerization ≥ 4); G (gallate) Mon (monomers) + Olig (oligomers) is the sum of (−) epicatechin gallate, monogalloylated dimer, monogalloylated dimer of type A, and monogalloylated trimer. MIC GM: geometric mean MIC against Candida albicans reference strains (ATCC90028, ATCC3153, ATCC10261, ATCC10231, and ATCC24433) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3.
3.2. Chemical Composition of the Extracts

An example of the GSEs HPLC profiles in terms of monomers, oligomers, and polymers is shown in Figure 1. Optimizing the chromatographic method also with the help of an RP 18 Poroshell column several monomer and oligomer compounds have been separated and quantified in all the fifteen extracts (Table 5). The identification of the phenols listed in Table 5 has been done by mean of their UV and mass spectra, by the use of pure standards ((+) catechin; (−) epicatechin; procyanidin B1 and B2; ECg) and according to the literature [2022]. Moreover, two groups of polymeric procyanidins (Pol 1 and Pol 2) with a polymerization degree ≥4 have been separated and determined by their mass spectra in negative-ionization mode (Figure 1 and Table 5).

The chemical composition of the different extracts correlated to their antifungal activity against C. albicans reference strains is summarized in Table 5. The identified components in the GSEs typically belong to the flavan-3-ols class; (+) catechin and (−) epicatechin are the main monomers; within the polymeric forms 1 + 2 (from 40 to 96% of the total flavan-3-ols) are included some acylated forms with gallic acid residues. The extracts 1–4 and 15 (Table 5) showed the lowest content of flavan-3-ols and in particular the lowest content of polymeric forms compared with all the other samples (Table 5).

3.3. Antifungal Activity of M. Palieri V1N1 2010 GSE against Vaginal Candidiasis

M. Palieri V1N1 2010GSE has been chosen for in vivo test for best reproducibility of M. Palieri cultivar, confirmed in different years, in MIC values and in phenolic constituents. Moreover, we demonstrated that M. Palieri V1N1 2010 GSE treatment did not induce in vitro resistance on C. albicans ATCC 10231. The MIC value was of 16 mg/L both for control and for M. Palieri V1N1 2010 GSE-treated strain. The in vitro antifungal activity of MP V1N1 2010 GSE and FLC, against C. albicans gLUC59 used in in vivo test, showed MIC values of and  mg/L, respectively.

Antifungal activity of M. Palieri V1N1 2010 GSE against vaginal candidiasis was monitored in an experimental murine model of vaginal candidiasis that allowed the visualization of the temporal and spatial progression of infection. In particular the M. Palieri V1N1 2010 GSE was administered intravaginally (50 g/L, 10 μL/mouse) 2 h before the challenge and then it was repeated every two days until day +8. The results reported in Figure 2 showed a significant inhibition of C. albicans load observed 5 days after challenge. The effect was comparable to that observed with FLC. The infection was completely cleared 8 days after infection (Figure 2).

4. Discussion

In this work, for the first time, the in vitro anti-Candida activity of GSE from wine and table cultivars of Vitis vinifera L., grown in different agronomic conditions, collected over several years has been evaluated. The results showed that GSEs obtained from cultivars grown in Puglia under hydric stress possess potent antifungal activity in vitro, in some cases similar to that of FLC itself. All GSEs have been chemically characterized. A significant negative correlation coefficient of total flavan-3-ols contained in the different extracts and MIC values has been demonstrated (, ). Moreover, we demonstrated for the first time that the antifungal activity (MIC) of GSEs is attributable mostly to the polymeric flavan-3-ols (with a polymerization degree ≥4), with a significative negative correlation coefficient (, ) (Table 5). Differently, the content of gallate monomers and oligomers did not seem to be correlated to antifungal activity (, ). It is important to emphasize that the typical catechin of green tea, EGCg, known to be responsible of growth-inhibitory effect on clinical isolates of Candida spp. [10], is absent in our samples.

We demonstrated that Verdicchio and Abbuoto, not subjected to controlled agronomic conditions of water, collected in 2006 (samples 1-2), had a higher content of polymers 1 + 2 (with the polymer 2 from 3- to 10-fold higher) than the same cultivars collected in 2008 (Table 5). These differences could be partially attributable to the rainfall during 2008, twofold higher than that in 2006.

Hydric stress implies a bigger effort to absorb water from the soil and, as a consequence, a lesser vegetative growth and an increase of bioactive molecules production [23]. In particular, Cavaliere et al. demonstrated that the content of flavan-3-ols in grape seeds is influenced by several agronomic conditions mainly irrigation and nitrogen fertilization [11, 24].

In the present work, the dried GSEs obtained from the cultivars M. Palieri, Italia, Red Globe, and Negroamaro, cultured under hydric stress (V1 and V2) (samples 5–14 Table 5), showed the highest content of polymers 1 + 2 >250 mg/g with the polymer 2 >46 mg/g and the best antifungal activity with the GM MIC values between 5.7 and 20.2 mg/L against C. albicans reference strains (Table 5) as reported in the patent PCT/IT2011/000400 [25].

GSE, with 573 mg/g of polymeric flavan-3-ols, obtained from M. Palieri V1N1 2010, has been tested in an experimental murine model of vaginal candidiasis, by using noninvasive in vivo imaging technique. This GSE demonstrated to accelerate the clearance of fungus during vaginal candidiasis, with a significant inhibition of C. albicans load 5 days after challenge, evaluated by photon emission.

5. Conclusion

In conclusion, we demonstrated that GSEs obtained from Vitis vinifera plants, grown under hydric stress, had a high and reproducible content of polymeric flavan-3-ols, with a polymerization degree ≥4, and high antifungal activity. Further studies are in progress to characterize these polymeric fractions.

Moreover, we demonstrated, for the first time, anti-Candida activity of GSE in an experimental murine model of vaginal candidiasis.

These findings, together with lack of toxicity and easy way of preparation of the extracts, suggest that GSEs with high content of polymeric flavan-3-ols could be used in Candida infections.

Ethical Approval

All animal experiments were performed in agreement with the EU Directive 2010/63, the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, and the National Law 116/92. The protocol was approved by Perugia University Ethics Committee for Animal Care and Use (Permit no. 149/2009-B). All the animals were housed in the animal facility of the University of Perugia (Authorization no. 34/2003A) in microisolator boxes with autoclaved diets and wood chips. Mice were acclimatized for a week before starting the experiments. All efforts were made to minimize suffering during experiments.

Conflict of Interests

All the authors declare that they had no personal relationship with other people and organisations that could inappropriately influence our work. G. Pasqua, G. Simonetti, F. D. D’Auria, A. R. Santamaria, D. Antonacci, and N. Mulinacci are named inventors on a patent pending based on italian priority IT RM20100636 and related to “Extracts obtained from Vitis vinifera seeds and/or pomace and/or green grapes and/or stalks and uses thereof as antifungal agents” PCT/IT2011/000400, which is owned by Sapienza University (70%), CRA (20%), and University of Florence (10%). No commercial agreements are presently in place.

Acknowledgments

This work was supported by grants from the Ministry of Agricultural and Forestry Policy (MIPAF), Italy, in the framework of a program on grape quality, by the Project PON 01_01802, and by Ente Cassa di Risparmio di Firenze.

References

  1. J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, vol. 369, no. 9577, pp. 1961–1971, 2007. View at: Publisher Site | Google Scholar
  2. D. Pietrella, A. Rachini, M. Pines et al., “TH17 cells and IL-17 in protective immunity to vaginal candidiasis,” PLoS ONE, vol. 6, no. 7, Article ID e22770, 2011. View at: Publisher Site | Google Scholar
  3. A. Vecchiarelli, E. Pericolini, E. Gabrielli, and D. Pietrella, “New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges,” Frontiers in Microbiology, vol. 3, p. 294, 2012. View at: Publisher Site | Google Scholar
  4. G. del Gaudio, L. Lombardi, G. Maisetta et al., “Antifungal activity of the noncytotoxic human peptide hepcidin 20 against fluconazole-resistant Candida glabrata in human vaginal fluid,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 9, pp. 4314–4321, 2013. View at: Publisher Site | Google Scholar
  5. N. Tocci, G. Simonetti, F. D. D'Auria et al., “Root cultures of Hypericum perforatum subsp. angustifolium elicited with chitosan and production of xanthone-rich extracts with antifungal activity,” Applied Microbiology and Biotechnology, vol. 91, no. 4, pp. 977–987, 2011. View at: Publisher Site | Google Scholar
  6. N. Tocci, F. D'Auria, G. Simonetti et al., “A three-step culture system to increase the xanthone production and antifungal activity of Hypericum perforatum subsp. angustifolium in vitro roots,” Plant Physiology and Biochemistry, vol. 572, pp. 54–55, 2012. View at: Google Scholar
  7. Á. M. Alonso Borbalán, L. Zorro, D. A. Guillén, and C. G. J. Barroso, “Study of the polyphenol content of red and white grape varieties by liquid chromatography-mass spectrometry and its relationship to antioxidant power,” Journal of Chromatography A, vol. 1012, no. 1, pp. 31–38, 2003. View at: Publisher Site | Google Scholar
  8. M. Daglia, “Polyphenols as antimicrobial agents,” Current Opinion in Biotechnology, vol. 23, no. 2, pp. 174–181, 2012. View at: Publisher Site | Google Scholar
  9. G. Ozkan, S. Ulusoy, A. Orem et al., “Mechanisms of action: physiological effects. How does colistin-induced nephropathy develop and can it be treated?” Antimicrobial Agents and Chemotherapy, vol. 57, pp. 3463–3469, 2013. View at: Google Scholar
  10. M. Hirasawa and K. Takada, “Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 2, pp. 225–229, 2004. View at: Publisher Site | Google Scholar
  11. C. Cavaliere, P. Foglia, F. Marini, R. Samperi, D. Antonacci, and A. Laganà, “The interactive effects of irrigation, nitrogen fertilisation rate, delayed harvest and storage on the polyphenol content in red grape (Vitis vinifera) berries: a factorial experimental design,” Food Chemistry, vol. 122, no. 4, pp. 1176–1184, 2010. View at: Publisher Site | Google Scholar
  12. P. Giorio and V. Nuzzo, “Leaf area, light environment, and gas exchange in Montepulciano grapevines trained to Tendone trellising system,” Plant Biosystems, vol. 146, pp. 322–333, 2012. View at: Google Scholar
  13. B. Enjalbert, A. Rachini, G. Vediyappan et al., “A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections,” Infection and Immunity, vol. 77, no. 11, pp. 4847–4858, 2009. View at: Publisher Site | Google Scholar
  14. D. Pietrella, L. Angiolella, E. Vavala et al., “Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection,” BMC Complementary and Alternative Medicine, vol. 11, article 18, 2011. View at: Publisher Site | Google Scholar
  15. Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, Document M27-A3, CLSI, Wayne, Pa, USA, 3rd edition, 2008.
  16. Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement, Document M27-S3, CLSI, Wayne, Pa, USA, 2008.
  17. K. S. Barker, S. Crisp, N. Wiederhold et al., “Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans,” Journal of Antimicrobial Chemotherapy, vol. 54, no. 2, pp. 376–385, 2004. View at: Publisher Site | Google Scholar
  18. P. L. Fidel Jr., M. E. Lynch, and J. D. Sobel, “Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis,” Infection and Immunity, vol. 61, no. 10, pp. 4202–4207, 1993. View at: Google Scholar
  19. C. D'Enfert, A. Vecchiarelli, and A. J. P. Brown, “Bioluminescent fungi for real-time monitoring of fungal infections,” Virulence, vol. 1, no. 3, pp. 174–176, 2010. View at: Google Scholar
  20. K. Kondo, M. Kurihara, K. Fukuhara et al., “Conversion of procyanidin B-type (catechin dimer) to A-type: evidence for abstraction of C-2 hydrogen in catechin during radical oxidation,” Tetrahedron Letters, vol. 41, no. 4, pp. 485–488, 2000. View at: Publisher Site | Google Scholar
  21. J. Hokkanen, S. Mattila, L. Jaakola, A. M. Pirttilä, and A. Tolonen, “Identification of phenolic compounds from lingonberry (Vaccinium vitis-idaea L.), Bilberry (v L.) andHybrid Bilberry (Vaccinium x intermedium Ruthe L.) Leaves,” Journal of Agricultural and Food Chemistry, vol. 57, no. 20, pp. 9437–9447, 2009. View at: Publisher Site | Google Scholar
  22. C. P. Passos, S. M. Cardoso, M. R. M. Domingues, P. Domingues, C. M. Silva, and M. A. Coimbra, “Evidence for galloylated type-A procyanidins in grape seeds,” Food Chemistry, vol. 105, no. 4, pp. 1457–1467, 2007. View at: Publisher Site | Google Scholar
  23. N. Chaves and J. C. Escudero, “Variation of flavonoid synthesis induced by ecological factors,” in Principles and Practices in Plant Ecology, S. Inderjit, K. M. M. Dakshini, and C. L. Foy, Eds., CRC Press, Boca Raton, Fla, USA, 1999. View at: Google Scholar
  24. C. Cavaliere, P. Foglia, R. Gubbiotti, P. Sacchetti, R. Samperi, and A. Laganà, “Rapid-resolution liquid chromatography/mass spectrometry for determination and quantitation of polyphenols in grape berries,” Rapid Communications in Mass Spectrometry, vol. 22, no. 20, pp. 3089–3099, 2008. View at: Publisher Site | Google Scholar
  25. G. Pasqua, G. Simonetti, F. D. D’uria, A. R. Santamaria, D. Antonacci, and N. Mulinacci, Patent Pending Based on Italian Priority IT RM20100636 and Related to “Extracts obtained from Vitis vinifera seeds and/or pomace and/or green grapes and/or stalks and uses thereof as antifungal agents” PCT/IT 2011/000400, 2013.

Copyright © 2014 Giovanna Simonetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

2497 Views | 784 Downloads | 21 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.